Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;9(4):133-144.
doi: 10.1007/s40139-021-00227-z. Epub 2021 Nov 24.

Toxicology of Nanoparticles in Drug Delivery

Affiliations
Review

Toxicology of Nanoparticles in Drug Delivery

Swati Sharma et al. Curr Pathobiol Rep. 2021.

Abstract

Nanoparticles have revolutionized biomedicine especially in the field of drug delivery due to their intriguing properties such as systemic stability, level of solubility, and target site specificity. It can, however, be both beneficial and damaging depending on the properties in different environments, thus highlighting the importance of nanotoxicology studies before use in humans. Different types of nanoparticles have been used in drug delivery, and this review summarizes the recent toxicity studies of these nanoparticles. The toxicological evaluation of three widely used nanoparticles in drug delivery that are metal, lipid, and protein nanoparticles has been discussed in detail. Studies have recorded several toxic effects of various nanoparticles such as metal-based nanoparticles have been linked to increased oxidative stress and have the potential to infiltrate the cell nucleus and protein-based nanoparticles have been observed to have hepatotoxicity and nephrotoxicity as their adverse effects. Considering the increasing application of nanoparticles in drug delivery and the growing concerns of regulatory authorities regarding the toxicity of nanocarriers in living organisms, it requires urgent attention to identify the gap in toxicity studies. The review highlights the gap in toxicity studies and potential focus areas to overcome the existing challenges.

Keywords: Lipid nanoparticles; Metal nanoparticles; Nanoparticles; Nanotoxicology; Protein nanoparticles; Toxicity assessment.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestSwati Sharma, Roza Parveen, and Dr. Biswa Prasun Chatterji declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Biomedical applications of nanotherapeutics
Fig. 2
Fig. 2
Toxicity recorded by protein-based nanoparticles, lipid-based nanoparticles, and metal nanoparticles

Similar articles

Cited by

References

    1. Khana I, Saeed K, IdreesKhan. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019; 908–93. 10.1016/j.arabjc.2017.05.011.
    1. Mehta RV. Synthesis of magnetic nanoparticles and their dispersions with special reference to applications in biomedicine and biotechnology. Mater Sci Eng C. 2017;79:901–916. doi: 10.1016/j.msec.2017.05.135. - DOI - PubMed
    1. Zahin Nuzhat, Anwar Raihanatul, Tewari Devesh, Kabir MT, et al. Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery. Environ Sci Pollut Res. 2019;27:19151–19168. doi: 10.1007/s11356-019-05211-0. - DOI - PubMed
    1. Hasan A, Morshed M, Memic A, Hassan S, et al. Nanoparticles in tissue engineering: applications, challenges and prospects. 2018:13: 5637–5655. 10.2147/IJN.S153758. - PMC - PubMed
    1. Prasad M, Lambe UP, Brar B, lShah I, et al. Nanotherapeutics: an insight into healthcare and multi-dimensional applications in the medical sector of the modern world 2018:97: 1521–1537. 10.1016/j.biopha.2017.11.026. - PubMed

LinkOut - more resources